Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapiesPRNewsWire • 04/01/26
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to KnowZacks Investment Research • 03/31/26
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?Zacks Investment Research • 03/24/26
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30PRNewsWire • 03/24/26
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?Zacks Investment Research • 03/23/26
CAH Posts Strong Cash Flow, Eyes Next Steps in Capital DeploymentZacks Investment Research • 03/19/26
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 03/19/26
Cardinal Health (CAH) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 03/18/26
Defense IPO Leads Five Stocks To Watch As Iran War Pressures MarketInvestors Business Daily • 03/14/26
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?Zacks Investment Research • 03/13/26
Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26?Zacks Investment Research • 03/12/26
Cardinal Health, Inc. (CAH) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
Cardinal Health, Inc. (CAH) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/09/26
Cardinal Health report highlights cost savings and provider confidence in biosimilarsPRNewsWire • 02/24/26
20 stocks of companies that delivered a double dose of growth this earnings seasonMarket Watch • 02/11/26
Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)Seeking Alpha • 02/07/26